Treatment of cholestasis and cholestatic disorders.
The future of therapy of chronic cholestatic disorders is bright given the large number of new drugs that are in the initial phases of study. UDCA is currently the mainstay of therapy.
Sanyal
A
A
Medical College of Virginia, Virginia Commonwealth University, VA, USA.
D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002779:Cholestasis / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid